Pancreatic Cancer Research

ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years

Ke Lei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2523-5530; OpenAlex author ID A5082212775, A5103181880. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper

Papers 6

  1. EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer. Co-author DOI 10.1002/mco2.70860↗
  2. hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.217436↗
  3. HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.2174/1566523223666230720101531↗
  4. Expression landscape of cancer-FOXP3 and its prognostic value in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.216838↗
  5. hnRNPAB Promotes Pancreatic Ductal Adenocarcinoma Extravasation and Liver Metastasis by Stabilizing MYC mRNA. Co-author DOI 10.1158/1541-7786.mcr-24-0110↗
  6. GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2022.06.006↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. He Ren · 6 shared papers, 2022–2026 · strength 1.34
  2. Ruining Gong · 5 shared papers, 2024–2026 · strength 1.18
  3. Xianghan Chen · 4 shared papers, 2024–2025 · strength 0.90
  4. Qian Yu · 2 shared papers, 2025 · strength 0.51
  5. Jigang Wang · 2 shared papers, 2024–2025 · strength 0.44
  6. Ruoxi Xiao · 1 shared paper, 2026 · strength 0.28
  7. Junjin Wang · 1 shared paper, 2026 · strength 0.28
  8. Boyi Ma · 1 shared paper, 2025 · strength 0.27
  9. Ashok Kumar Saluja · 1 shared paper, 2025 · strength 0.25
  10. Xiaoyuan Sun · 1 shared paper, 2022 · strength 0.16
  11. Tongsen Zheng · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.